Dr. Kailas Datkhile | Oncology | Research Excellence Award

Dr. Kailas Datkhile, Krishna Vishwa Vidyapeeth (Deemed to be University), India

Dr. Kailas Dhondibhau Datkhile is an accomplished Senior Research Officer and Incharge of the Molecular & Genetics Laboratory at Krishna Institute of Medical Sciences University, Karad. With over 22 years of research experience, his work spans across Cell and Molecular Biology, Genetic Engineering, and Biotechnology. He has been actively involved in investigating molecular markers related to cancers such as breast, cervical, and oral cancer. Dr. Datkhile holds a Post-Doctorate and Ph.D. in Biotechnology from the University of Pune, where he also worked on groundbreaking research in radiation tolerance in Indian midge Chironomus ramosus. His contributions include 99 research publications and participation in numerous conferences. Dr. Datkhile’s expertise extends to a variety of biotechnological applications, making him a leading figure in his field.

Professional Profile

scopus

orcid

google scholar

Summary of Suitability for the Research for Research Excellence Award

Dr. Kailas Dhondibhau Datkhile presents a highly impressive research portfolio, making him a strong candidate for the Research for Research Excellence Award. With over 22 years of research experience in biotechnology and molecular genetics, his current work focuses on understanding molecular markers in cancers such as breast, cervical, and oral cancer, which is a critical area of medical research with significant societal impact. His deep expertise in cell and molecular biology, recombinant DNA technology, and genetic engineering reflects a broad and sophisticated research skill set.

Education

Dr. Datkhile earned his Post-Doctorate in Biotechnology in 2012 from the University of Pune’s Department of Biotechnology. His Ph.D., completed in 2010 at the University of Pune’s Department of Zoology, focused on cellular and molecular responses to gamma radiation in Indian midges. He also holds an M.Sc. in Botany, completed in 2002, and a B.Sc. in Botany, completed in 2000, both from the University of Pune, where he graduated with First Class and First Class with Distinction, respectively. His educational journey reflects a deep commitment to molecular biology and biotechnology, where he laid a foundation for his research in cancer markers, plant metabolism, and genetic studies. This academic background, coupled with hands-on experimental work in prominent research labs, shaped his expertise in molecular and genetic studies.

Experience

Dr. Datkhile has extensive research experience spanning over 22 years, having begun his career as a research fellow under the BARC-UoP collaborative program at the Bhabha Atomic Research Centre. Currently, he is the Senior Research Officer and Laboratory Incharge at Krishna Institute of Medical Sciences University. His postdoctoral work involved significant projects on molecular characterization in midges and mosquitoes, supported by the University Grant Commission. His teaching experience dates back to 2004, where he conducted practicals and supervised MSc students during his doctoral and postdoctoral research. Dr. Datkhile has also worked as a project assistant at the National Chemical Laboratory in Pune, contributing to the Micropropagation R&D Improvement program. His breadth of experience encompasses molecular biology, genetic engineering, tissue culture, and microbiology, making him a leader in experimental research and biotechnology applications.

Awards and Honors

Dr. Datkhile’s academic and research excellence has earned him numerous awards, including the prestigious Dr. D. S. Kothari Post-Doctoral Fellowship (2010-2012), funded by the University Grants Commission (UGC) of India. His research in molecular genetics and biotechnology has been recognized at national and international levels, with over 99 publications in reputed journals. Dr. Datkhile has also been an invited speaker and presenter at 12 international conferences and workshops, further solidifying his reputation as a thought leader in biotechnology. His innovative research in radiation tolerance and cancer-related molecular markers has set him apart in the scientific community. He continues to receive recognition for his contributions to cancer research, cell and molecular biology, and genetic engineering.

Research Focus

Dr. Datkhile’s research primarily focuses on the identification and regulation of molecular markers in cancers such as breast, cervical, and oral cancer. His postdoctoral research examined eukaryotic translation initiation factors in mosquitoes and midges, contributing to understanding molecular responses to external stimuli like radiation. His Ph.D. work on the Indian midge’s gamma radiation tolerance opened new avenues in cellular and molecular biology. Currently, Dr. Datkhile is investigating novel genetic markers that may play a pivotal role in cancer diagnostics and treatment. His expertise in cell biology, recombinant DNA technology, and tissue culture techniques supports his efforts to advance cancer research and genetic studies. Additionally, his work involves the development of new diagnostic tools through molecular and genetic engineering.

Publicatiom Top Notes

Title: Increased level of superoxide dismutase (SOD) activity in larvae of Chironomus ramosus (Diptera: Chironomidae) subjected to ionizing radiation

Cited by: 63
Title: Biogenic silver nanoparticles are equally cytotoxic so as chemically synthesized silver nanoparticles

Cited by: 37
Title: Biogenic synthesis of gold nanoparticles using Argemone mexicana L. and their cytotoxic and genotoxic effects on human colon cancer cell line (HCT-15)

Cited by: 36
Title: Studies on Phytoconstituents, in vitro Antioxidant, Antibacterial, Antiparasitic, Antimicrobial, and Anticancer Potential of Medicinal Plant Lasiosiphon eriocephalus Decne

Cited by: 36
Title: Studies on phytoconstituents, in vitro antioxidant, antibacterial, and cytotoxicity potential of Argemone mexicana Linn. (Family: Papaveraceae)

Cited by: 34

Dr. Stela Dragomanova, Medical University of Varna, Bulgaria

Dr. Stela Dragomanova is a distinguished researcher and educator at the Medical University of Varna. She earned her master’s degree in Pharmacy from the Medical University of Sofia in 2004 and later specialized in Clinical Pharmacy. In 2020, she completed her Ph.D. in Pharmacology at the Institute of Neurobiology, Bulgarian Academy of Sciences. Dr. Dragomanova’s research centers on neuropharmacology, particularly neurodegenerative diseases. She is a member of the Bulgarian Pharmaceutical Union and serves as Chairlady of the Ethics Committee for the Regional Pharmaceutical Collegium in Varna. Dr. Dragomanova has published 30+ peer-reviewed papers, contributing significantly to pharmacology and neuroscience. She has also served as Assistant Professor from 2010 to 2021 and is currently Chief Assistant Professor in the Department of Pharmacology at the Medical University of Varna.

Summary of Suitability for the Research for Best Researcher Award

Dr. Stela Dragomanova demonstrates a strong profile as a candidate for the Research for Best Researcher Award. With a Ph.D. in Pharmacology and a focus on neuropharmacology, her research is centered around neurodegenerative diseases, a critical area of biomedical research. Her expertise in in vivo preclinical models and behavioral tests positions her as a valuable contributor to the scientific community, particularly in neuropharmacology and toxicology.Her academic career includes over a decade of teaching and research at the Medical University of Varna, Bulgaria, where she has steadily advanced from Assistant Professor to Chief Assistant Professor. Dr. Dragomanova has also made substantial contributions to the scientific literature, with 30+ publications, including articles in high-impact journals such as Antioxidants and Molecules, with topics addressing neuroprotective strategies and experimental pharmacology.

Education

Dr. Stela Dragomanova began her academic journey at the Medical University of Sofia, where she obtained her master’s degree in Pharmacy in 2004. She further specialized in Clinical Pharmacy, enhancing her expertise in pharmacological interventions. Driven by her passion for neuropharmacology, Dr. Dragomanova pursued her Ph.D. in Pharmacology at the Bulgarian Academy of Sciences’ Institute of Neurobiology, completing it in 2020. Her doctoral research provided significant insights into neurodegenerative diseases and related pharmacotherapies. With a strong foundation in experimental pharmacology and toxicology, Dr. Dragomanova is equipped with advanced skills in preclinical in vivo models and behavioral testing. Her academic qualifications, coupled with her research experience, reflect her commitment to advancing knowledge in the pharmaceutical and neuropharmacological fields.

Experience

Dr. Stela Dragomanova has been an integral part of the Medical University of Varna since 2010, starting as an Assistant Professor in the Department of Pharmacology, Toxicology, and Pharmacotherapy. She transitioned into the role of Chief Assistant Professor in 2021, where she continues to lead and mentor young scientists in neuropharmacology. In her academic career, she has overseen numerous research projects focusing on neurodegenerative disorders, particularly in exploring neuroprotective agents and pharmacological treatments. She has extensive expertise in in vivo preclinical models and behavioral testing in experimental pharmacology. Dr. Dragomanova is also deeply involved in regulatory and ethical aspects of pharmacology research, serving as the Chairlady of the Ethics Committee for the Regional Pharmaceutical Collegium in Varna and being an active member of several scientific and pharmaceutical associations.

Awards and Honors

Dr. Stela Dragomanova has been recognized for her outstanding contributions to the field of pharmacology and her dedication to healthcare and education. In 2018, she was named “Pharmacist of the Year” for the Varna region by the Regional Pharmaceutical Collegium. This prestigious award highlights her commitment to the pharmaceutical profession and the positive impact of her work in the healthcare sector. In addition to her regional recognition, Dr. Dragomanova is an esteemed member of the Bulgarian Pharmaceutical Union, which is part of the Pharmaceutical Group of the European Union (PGEU). She also holds leadership roles in several academic and professional organizations, including the Bulgarian Association of Pharmacology, Clinical Pharmacology, and Therapeutics. Her extensive experience in both research and education further solidifies her as a prominent figure in the pharmacological sciences.

Research Focus

Dr. Stela Dragomanova’s research is primarily focused on neuropharmacology, particularly in understanding the mechanisms underlying neurodegenerative diseases. Her work aims to discover potential therapeutic agents that can mitigate the progression of disorders such as Alzheimer’s and Parkinson’s disease. She has developed expertise in using in vivo preclinical models to evaluate neuroprotective compounds and conduct behavioral tests. Her research explores the role of antioxidants and polyphenols, studying their neuroprotective effects and potential applications in pharmacotherapy. Additionally, Dr. Dragomanova is interested in the therapeutic potential of lipid emulsions in treating convulsions and other toxicological conditions. Her investigations have led to a deeper understanding of the molecular and biochemical processes that drive neurodegeneration, with a strong focus on developing novel interventions for these challenging medical conditions.

Publications Top Notes